NASDAQ
APM

Aptorum Group Ltd Class A

PHARMACEUTICAL PREPARATIONS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Aptorum Group Ltd Class A Stock Price

Vitals

Today's Low:
$0.6300
Today's High:
$0.7300
Open Price:
$0.6800
52W Low:
$0.576
52W High:
$2.56
Prev. Close:
$0.6688
Volume:
39862

Company Statistics

Market Cap.:
$0.022 billion
Book Value:
0.634
Revenue TTM:
$0.001 billion
Operating Margin TTM:
-1269%
Gross Profit TTM:
$0.000 billion
Gross Profit TTM:
$0.000 billion
Profit Margin:
0%
Return on Assets TTM:
-40.7%
Return on Equity TTM:
-60.5%

Company Profile

Aptorum Group Ltd Class A had its IPO on 2018-12-18 under the ticker symbol APM.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Aptorum Group Ltd Class A has a staff strength of 0 employees.

Stock update

Shares of Aptorum Group Ltd Class A opened at $0.68 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $0.63 - $0.73, and closed at $0.63.

This is a -5.8% slip from the previous day's closing price.

A total volume of 39,862 shares were traded at the close of the day’s session.

In the last one week, shares of Aptorum Group Ltd Class A have slipped by -37%.

Aptorum Group Ltd Class A's Key Ratios

Aptorum Group Ltd Class A has a market cap of $0.022 billion, indicating a price to book ratio of 1.001 and a price to sales ratio of 15.71.

In the last 12-months Aptorum Group Ltd Class A’s revenue was $0.001 billion with a gross profit of $0.000 billion and an EBITDA of $-0.017 billion. The EBITDA ratio measures Aptorum Group Ltd Class A's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Aptorum Group Ltd Class A’s operating margin was -1269% while its return on assets stood at -40.7% with a return of equity of -60.5%.

In Q2, Aptorum Group Ltd Class A’s quarterly earnings growth was a positive 0% while revenue growth was a negative 17.3%.

Aptorum Group Ltd Class A’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
None

Its diluted EPS in the last 12-months stands at $-0.715 per share while it has a forward price to earnings multiple of - and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Aptorum Group Ltd Class A’s profitability.

Aptorum Group Ltd Class A stock is trading at a EV to sales ratio of 15.35 and a EV to EBITDA ratio of -0.886. Its price to sales ratio in the trailing 12-months stood at 15.71.

Aptorum Group Ltd Class A stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Aptorum Group Ltd Class A ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Aptorum Group Ltd Class A ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Aptorum Group Ltd Class A’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Aptorum Group Ltd Class A's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Aptorum Group Ltd Class A paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$0.63
52-Week High
$2.56
52-Week Low
$0.576
Analyst Target Price
$11.5

Aptorum Group Ltd Class A stock is currently trading at $0.63 per share. It touched a 52-week high of $2.56 and a 52-week low of $2.56. Analysts tracking the stock have a 12-month average target price of $11.5.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Aptorum Group Ltd Class A

The stock symbol (also called stock or share ticker) of Aptorum Group Ltd Class A is APM

The IPO of Aptorum Group Ltd Class A took place on 2018-12-18

Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)

Last Price
Chg
Chg%
$12.97
-0.23
-1.71%
$2.74
-0.02
-0.72%
CorMedix Inc (CRMD)
$2.95
-0.15
-4.84%
$4.76
0.05
+1.06%
$0.89
-0.07
-6.97%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Aptorum Group Limited, a pharmaceutical company, is dedicated to the discovery, development and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. The company is headquartered in London, the United Kingdom.

Address

17 HANOVER SQUARE, LONDON, GB